1. Home
  2. FREY vs OBIO Comparison

FREY vs OBIO Comparison

Compare FREY & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FREY
  • OBIO
  • Stock Information
  • Founded
  • FREY 2018
  • OBIO 2017
  • Country
  • FREY Luxembourg
  • OBIO United States
  • Employees
  • FREY N/A
  • OBIO N/A
  • Industry
  • FREY Industrial Machinery/Components
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • FREY Miscellaneous
  • OBIO Health Care
  • Exchange
  • FREY Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • FREY 310.1M
  • OBIO 291.7M
  • IPO Year
  • FREY N/A
  • OBIO N/A
  • Fundamental
  • Price
  • FREY $1.69
  • OBIO $8.03
  • Analyst Decision
  • FREY Hold
  • OBIO Strong Buy
  • Analyst Count
  • FREY 5
  • OBIO 2
  • Target Price
  • FREY $4.63
  • OBIO $17.00
  • AVG Volume (30 Days)
  • FREY 2.4M
  • OBIO 249.9K
  • Earning Date
  • FREY 08-08-2024
  • OBIO 08-08-2024
  • Dividend Yield
  • FREY N/A
  • OBIO N/A
  • EPS Growth
  • FREY N/A
  • OBIO N/A
  • EPS
  • FREY N/A
  • OBIO N/A
  • Revenue
  • FREY N/A
  • OBIO $2,216,000.00
  • Revenue This Year
  • FREY N/A
  • OBIO $17.90
  • Revenue Next Year
  • FREY $7,958.52
  • OBIO $10.51
  • P/E Ratio
  • FREY N/A
  • OBIO N/A
  • Revenue Growth
  • FREY N/A
  • OBIO N/A
  • 52 Week Low
  • FREY $1.21
  • OBIO $4.22
  • 52 Week High
  • FREY $8.53
  • OBIO $11.69
  • Technical
  • Relative Strength Index (RSI)
  • FREY 45.79
  • OBIO 54.75
  • Support Level
  • FREY $1.72
  • OBIO $7.80
  • Resistance Level
  • FREY $2.03
  • OBIO $8.87
  • Average True Range (ATR)
  • FREY 0.13
  • OBIO 0.60
  • MACD
  • FREY 0.03
  • OBIO -0.01
  • Stochastic Oscillator
  • FREY 35.00
  • OBIO 59.02

About FREY FREYR Battery Inc.

FREYR Battery Inc is an emerging producer of clean battery solutions for the planet. It designs and manufactures high-density and cost-competitive lithium-ion batteries with a reduced carbon footprint for the markets for electric mobility, stationary energy storage, and marine and aviation applications.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: